Augmentation of serum bactericidal activity by paldimycin.

J Antibiot (Tokyo)

Research Laboratories, Upjohn Company, Kalamazoo, MI 49001.

Published: May 1988

At concentrations below the MIC, paldimycin induced changes in Staphylococcus aureus 502A (UC 9116, ATCC 28417) which increased its sensitivity to serum. The enhanced sensitivity to serum was concentration dependent with the maximal sensitivity found when bacteria were grown in approximately 1/10 MIC of paldimycin. Within an 1-hour incubation, S. aureus 502A typically grew 1.5-2-fold in serum. Following exposure to paldimycin, however, approximately 30-50% of the bacteria were killed in serum. The paldimycin treated bacteria were not more susceptible to phagocytosis and killing by polymorphonuclear leukocytes. At the concentrations utilized, the Staphylococci were enlarged and had thickened cell walls. The organisms were still viable and replicating, but irregularities in cell division were observed in transmission electron micrographs.

Download full-text PDF

Source
http://dx.doi.org/10.7164/antibiotics.41.660DOI Listing

Publication Analysis

Top Keywords

mic paldimycin
8
aureus 502a
8
sensitivity serum
8
paldimycin
5
augmentation serum
4
serum bactericidal
4
bactericidal activity
4
activity paldimycin
4
paldimycin concentrations
4
concentrations mic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!